Zentiva rejects PPF and Generali
Zentiva, a generic drugs company based in the Czech Republic, has rejected an ``opportunistic'' US$2.32bn takeover bid by financial group PPF and Italian insurer Generali, which together own 19% of Zentiva.
The mis selling of PPI is still rife according to the FOS.